KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacira BioSciences (PCRX) Goodwill & Intangibles: 2009-2024

Historic Goodwill & Intangibles for Pacira BioSciences (PCRX) over the last 16 years, with Dec 2024 value amounting to $426.0 million.

  • Pacira BioSciences' Goodwill & Intangibles fell 8.54% to $402.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $402.7 million, marking a year-over-year decrease of 8.54%. This contributed to the annual value of $426.0 million for FY2024, which is 34.11% down from last year.
  • Per Pacira BioSciences' latest filing, its Goodwill & Intangibles stood at $426.0 million for FY2024, which was down 34.11% from $646.5 million recorded in FY2023.
  • In the past 5 years, Pacira BioSciences' Goodwill & Intangibles registered a high of $769.2 million during FY2021, and its lowest value of $196.1 million during FY2020.
  • Moreover, its 3-year median value for Goodwill & Intangibles was $646.5 million (2023), whereas its average is $592.1 million.
  • As far as peak fluctuations go, Pacira BioSciences' Goodwill & Intangibles soared by 292.30% in 2021, and later tumbled by 34.11% in 2024.
  • Over the past 5 years, Pacira BioSciences' Goodwill & Intangibles (Yearly) stood at $196.1 million in 2020, then spiked by 292.30% to $769.2 million in 2021, then decreased by 8.50% to $703.8 million in 2022, then dropped by 8.14% to $646.5 million in 2023, then crashed by 34.11% to $426.0 million in 2024.